CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 43 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-12 | BOLL ANDREW R. PRESIDENT AND CFO | Shares withheld for taxes | −26,665 | $47.06 | $1.3M | 811,179 |
| 2025-12-12 | BOLL ANDREW R. PRESIDENT AND CFO | Option exercise · Stock Option (Right to Buy) | −60,000 | 0 | ||
| 2025-12-12 | BAUM MARK L CHIEF EXECUTIVE OFFICER | Option exercise | +180,000 | $3.95 | $711K | 3,066,124 |
| 2025-12-12 | BAUM MARK L CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −79,994 | $47.06 | $3.8M | 2,986,130 |
| 2025-12-12 | BAUM MARK L CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (Right to Buy) | −180,000 | 0 | ||
| 2025-09-01 | Pollard Randall E. CHIEF ACCOUNTING OFFICER | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2025-07-21 | BAUM MARK L CHIEF EXECUTIVE OFFICER | Option exercise | +600,000 | $7.87 | $4.7M | 3,199,462 |
| 2025-07-21 | BAUM MARK L CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −313,338 | $37.08 | $11.6M | 2,886,124 |
| 2025-07-01 | BOLL ANDREW R. CHIEF FINANCIAL OFFICER | Grant or award · RSU | +405,750 | 405,750 | ||
| 2025-07-01 | BAUM MARK L CHIEF EXECUTIVE OFFICER | Grant or award · RSU | +889,500 | 889,500 | ||
| 2025-06-20 | Sternberg Perry J. Director | Grant or award · RSU | +7,339 | 7,339 | ||
| 2025-06-20 | SILVERNAIL LAUREN P Director | Grant or award · RSU | +7,339 | 7,339 | ||
| 2025-06-20 | Graves Adrienne L Director | Grant or award · RSU | +7,339 | 7,339 | ||
| 2025-06-10 | Opaleye Management Inc. 10% owner | Sale | −15,000 | $30.80 | $462K | 90,000 |
| 2025-06-09 | Opaleye Management Inc. 10% owner | Sale | −15,204 | $30.37 | $462K | 105,000 |
| 2025-06-04 | Opaleye Management Inc. 10% owner | Sale | −1,796 | $30.02 | $54K | 120,204 |
| 2025-06-03 | Opaleye Management Inc. 10% owner | Sale | −3,000 | $30.04 | $90K | 122,000 |
| 2025-05-13 | Opaleye Management Inc. 10% owner | Sale | −5,000 | $26.59 | $133K | 125,000 |
| 2025-05-12 | Opaleye Management Inc. 10% owner | Sale | −10,000 | $25.90 | $259K | 130,000 |
| 2025-04-07 | BOLL ANDREW R. Chief Financial Officer | Shares withheld for taxes | −136,745 | $23.09 | $3.2M | 777,844 |
Page 2 of 17 · 336 trades